Fmr LLC Pro Qr Therapeutics N.V. Transaction History

Fmr LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.56 - $1.0 $0 - $1	-1 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.9 - $8.39 $4.02 Million - $37.4 Million	-4,462,437 Reduced 100.0%	1 $0
Q4 2021 Feb 14, 2022	SELL	$6.58 - $8.44 $2.18 Million - $2.79 Million	-330,835 Reduced 6.9%	4,462,438 $35.7 Million
Q3 2021 Nov 15, 2021	BUY	$5.16 - $8.47 $216,069 - $354,672	41,874 Added 0.88%	4,793,273 $40.1 Million
Q2 2021 Aug 13, 2021	BUY	$5.75 - $7.59 $27.3 Million - $36.1 Million	4,751,399 New	4,751,399 $32 Million

17.3M

26.2K

8.6K

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $249M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

Stay updated on Fmr LLC with notifications on news.